title: Rebuttal from Drs Schröder-Bäck and Martakis.
authors.affiliation: Department of International Health, CAPHRI-School of Public Health and Primary Care, Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, The Netherlands; Faculty for Human and Health Sciences, University of Bremen, Bremen, Germany. Electronic address: Peter.Schroder@maastrichtuniversity.nl.
authors.forename: Peter
authors.initials: P
authors.lastname: Schröder-Bäck
authors.affiliation: Department of International Health, CAPHRI-School of Public Health and Primary Care, Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, The Netherlands; Children's and Adolescents' Hospital, University Hospital of Cologne, Cologne, Germany.
authors.forename: Kyriakos
authors.initials: K
authors.lastname: Martakis
mesh_terms: D035843:Biomedical Research / Q000458:organization & administration*; D004196:Disease Outbreaks / Q000517:prevention & control*; D006801:Humans; D037141:Mandatory Programs / Q000458:organization & administration*; D008457:Measles / Q000517:prevention & control*; D008458:Measles Vaccine / Q000494:pharmacology*; D011634:Public Health; D014611:Vaccination
chemical_list: D008458:Measles Vaccine